{"effective_time":"20171103","id":"13012917-0d0d-457b-9bca-ea9a0425f3d7","openfda":{},"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 250 mg Bottle Label NDC 24338-102-13 100 Tablets ERYTHROMYCIN TABLETS, USP Film-coated Tablets 250 mg Erythromycin, USP Tablet identification code format change adopted October, 2000. Rx only arbor PHARMACEUTICALS, LLC PRINCIPAL DISPLAY PANEL - 250 mg Bottle Label","PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label NDC 24338-104-13 100 Tablets ERYTHROMYCIN TABLETS, USP Film-coated Tablets 500 mg Erythromycin, USP Tablet identification code format change adopted October, 2000. Rx only arbor PHARMACEUTICALS, LLC PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label"],"set_id":"1faa5559-3eb6-409a-bcf0-9165b76177e4","spl_product_data_elements":["Erythromycin Erythromycin Erythromycin Erythromycin Silicon Dioxide croscarmellose sodium crospovidone D&C Red No. 30 aluminum oxide hydroxypropyl cellulose (type H) hypromelloses hypromellose phthalate (24% phthalate, 55 CST) magnesium stearate cellulose, microcrystalline povidones polyethylene glycols propylene glycol sodium citrate sodium hydroxide sorbic acid sorbitan monooleate talc titanium dioxide EB Erythromycin Erythromycin Erythromycin Erythromycin Silicon Dioxide croscarmellose sodium crospovidone D&C Red No. 30 aluminum oxide hydroxypropyl cellulose (type H) hypromelloses hypromellose phthalate (24% phthalate, 55 CST) magnesium stearate cellulose, microcrystalline povidones polyethylene glycols propylene glycol sodium citrate sodium hydroxide sorbic acid sorbitan monooleate talc titanium dioxide EA"],"spl_unclassified_section":[""],"version":"13"}